Last mentioned: May 5, 2026
Impurity Warning
Lilly issues formal warning after testing reveals impurities in compounded samples.
Compounding Surge
Shortage status triggers Section 503B exemptions, allowing pharmacies to mass-produce compounded versions.
Zepbound Approval
Tirzepatide approved for chronic weight management, exacerbating supply shortages.
Mounjaro FDA Approval
FDA approves tirzepatide for type 2 diabetes, leading to immediate high demand.
Eli Lilly has issued a formal warning regarding discovered impurities in compounded versions of its blockbuster weight-loss medication, tirzepatide. This development marks a significant escalation in the ongoing regulatory and legal conflict between pharmaceutical giants and the compounding industry over safety standards and patent enforcement.
This page surfaces every story mentioning Eli Lilly and Company across our legal coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running legal beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Eli Lilly and Company was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |